Memorial Sloan-Kettering Cancer Center is applying to continue as a Clinical Trials Member of the AIDS-associated Malignancies Clinical Trials Consortium (AMC). Our qualifications include: (1) A strong record of scientific and administrative contributions to the AMC since its inception in 1995; (2) Broad experience in the development and performance of innovative clinical trials, laboratory investigations and AIDS patient care relevant to the objectives of the AMC; (3) Expertise in infectious diseases required for the care of patients with AIDS- associated malignancies; (4) An extensive referral network that will facilitate accrual; (5) A well-developed clinical, laboratory and data management infrastructure and resources to support collection of tumor tissue and biological fluids for the AIDS Malignancy Banks; and, (6) A commitment to making AMC trials our highest priority. Particular strengths of our group include extensive experience in the early phase testing and evaluation of cytokines and cytokine modulators in cancer and AIDS; an active program for development and diagnostic and therapeutic applications of monoclonal antibodies in cancer; expertise in the development of novel therapeutic approaches for primary CNS lymphoma; expertise in the design, performance and analysis of phase I drug trials; and, experience in the diagnosis, treatment and monitoring of patients with HPV-associated anogenital squamous malignancies. Members of our group have been leaders in the analysis of prognostic factors in AIDS-associated KS and NHL and in the development of criteria for evaluating and staging AIDS-associated cancers, and have developed several innovative clinical trials for AIDS-associated malignancies that are in progress or being developed for future implementation through the AMC. In sum, our scientific and clinical resources make us uniquely positioned to continue to contribute to the collaborative clinical trials effort that has been developed in the AMC over the past 3 years.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA070054-09S2
Application #
7109451
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Bhatia, Kishor
Project Start
1995-09-30
Project End
2006-03-31
Budget Start
2003-08-01
Budget End
2006-03-31
Support Year
9
Fiscal Year
2005
Total Cost
$173,160
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Koon, Henry B; Fingleton, Barbara; Lee, Jeannette Y et al. (2011) Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr 56:64-8
Lechowicz, Maryjo; Dittmer, Dirk P; Lee, Jeannette Y et al. (2009) Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis 49:1946-9
Lin, Lan; Lee, Jeannette Y; Kaplan, Lawrence D et al. (2009) Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol 27:2496-502
Ratner, Lee; Harrington, William; Feng, Xuan et al. (2009) Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PLoS One 4:e4420
Brinker, Brett T; Krown, Susan E; Lee, Jeannette Y et al. (2008) Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer 112:1083-8
Stier, Elizabeth A; Goldstone, Stephen E; Berry, J Michael et al. (2008) Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 47:56-61
Spitzer, Thomas R; Ambinder, Richard F; Lee, Jeannette Y et al. (2008) Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant 14:59-66
Krown, Susan E (2007) AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa? Cytokine Growth Factor Rev 18:395-402
Noy, Ariela; von Roenn, Jamie; Politsmakher, Alex et al. (2007) Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma. AIDS 21:113-5
Krown, Susan E; Lee, Jeannette Y; Lin, Lan et al. (2006) Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr 41:149-53

Showing the most recent 10 out of 17 publications